LORD, ABBETT & CO. LLC

Holdings History for Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)

Symbol: RARE on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2022		-0.07%	$0	0	-324,724	-100%	$22.54	Q3 2022
30 Jun 2022	0.07%	+0%	$19,373,000	324,724	+10,980	+3.5%	$59.66	Q2 2022
31 Mar 2022	0.06%	+0%	$22,784,000	313,744	+63	+0.02%	$72.62	Q1 2022
31 Dec 2021	0.06%	-0.02%	$26,378,000	313,681	-116,225	-27%	$84.09	Q4 2021
30 Sep 2021	0.09%	+0.01%	$38,773,000	429,906	+65,097	+18%	$90.19	Q3 2021
30 Jun 2021	0.08%	-0%	$34,784,000	364,809	-13,017	-3.4%	$95.35	Q2 2021
31 Mar 2021	0.11%	+0.11%	$43,019,000	377,826	+377,826	NEW	$113.86	Q1 2021
31 Dec 2018		-0.06%	$0	0	-273,479	-100%	$22.54	Q4 2018
30 Sep 2018	0.06%	+0.06%	$20,877,000	273,479	+273,479	NEW	$76.34	Q3 2018
31 Dec 2016		-0.03%	$0	0	-157,176	-100%	$22.54	Q4 2016
30 Sep 2016	0.03%	-0.04%	$11,150,000	157,176	-179,977	-53%	$70.94	Q3 2016
30 Jun 2016	0.05%	+0.03%	$16,490,000	337,153	+181,270	+116%	$48.91	Q2 2016
31 Mar 2016	0.03%	-0.02%	$9,869,000	155,883	-123,830	-44%	$63.31	Q1 2016
31 Dec 2015	0.09%	+0.02%	$31,378,000	279,713	+48,133	+21%	$112.18	Q4 2015
30 Sep 2015	0.07%	-0.14%	$22,303,000	231,580	-496,079	-68%	$96.31	Q3 2015
30 Jun 2015	0.2%	+0.03%	$74,505,000	727,659	+99,327	+16%	$102.39	Q2 2015
31 Mar 2015	0.1%	+0.03%	$39,013,000	628,332	+200,916	+47%	$62.09	Q1 2015
31 Dec 2014	0.05%	-0.02%	$18,755,000	427,416	-150,215	-26%	$43.88	Q4 2014
30 Sep 2014	0.08%	+0.05%	$32,694,000	577,631	+345,765	+149%	$56.60	Q3 2014
30 Jun 2014	0.02%	+0.02%	$10,408,000	231,866	+177,722	+328%	$44.89	Q2 2014
31 Mar 2014	0.01%	+0.01%	$2,647,000	54,144	+54,144	NEW	$48.89	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.